Alpha-Lipoic Acid Wound Dressing for Chronic Wound Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chronic wounds face challenges in healing due to prolonged inflammation and excess reactive oxygen species (ROS) and matrix metalloproteinases (MMPs), which damage surrounding tissue and prevent normal wound healing.
Innovation Solution
A wound dressing comprising a biologically active composition of alpha-lipoic acid derivatives and gelatin, applied in conjunction with reduced pressure treatment, to reduce ROS levels and inhibit MMP activity, promoting tissue growth and healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional wound dressings are used to manage wound environment and moisture balance, then wound care is provided, but active promotion of wound healing is limited due to excess ROS and MMPs damaging new tissue
Solution Approach 1:
The patent applies antioxidants to convert the harmful effect of excess ROS into a beneficial outcome by neutralizing these free radicals. The antioxidants scavenge ROS, preventing them from damaging new tissue and allowing wound healing to proceed normally, thus converting the harmful oxidative environment into a conducive healing environment.
Solution Approach 2:
The patent introduces antioxidants as intermediary substances that mediate between the harmful ROS/MMPs and the new tissue forming in the wound. These antioxidants act as protective intermediaries that intercept and neutralize ROS before they can damage collagen and other extracellular matrix components, enabling healthy tissue regeneration.
2Reliability
If antioxidants are applied to reduce ROS levels, then tissue damage is reduced, but the complexity of treatment increases
Solution Approach 1:
The patent employs composite wound dressings that integrate antioxidants with traditional wound care materials. This composite approach combines the ROS-scavenging properties of antioxidants with the moisture-management and protective functions of conventional dressings, creating a multifunctional material that addresses multiple wound healing challenges simultaneously without requiring separate treatment steps.
3Reliability
If MMP inhibitors are used to prevent tissue breakdown, then new tissue formation is protected, but the natural wound healing process may be interfered with
Solution Approach 1:
The patent addresses excess MMP activity indirectly by neutralizing ROS through antioxidant application. Since ROS act as signaling molecules that recruit MMPs to the wound site, reducing ROS levels consequently reduces MMP recruitment and activity. This approach protects new tissue from MMP-mediated degradation while maintaining the natural regulatory balance of the wound healing process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination effectively reduces ROS and MMP activity, facilitating normal wound healing by creating a conducive environment for tissue regeneration and reducing inflammation, thereby enhancing the healing process of chronic wounds.
Implementation Method 1
a selection comprising an antioxidant and a proteolytic enzyme substrate
Implementation Method 2
gelatin or hydrolysates thereof... providing a sacrificial substrate for the MMPs
Implementation Method 3
applied in conjunction with reduced pressure treatment
Data Source
Figure 1
Figure 2
Figure 3~4A
AI summary
According to an illustrative embodiment a method to promote healing of a wound is provided comprising contacting the wound with a biologically active composition comprising a lipoic acid derivative and gelatin. In another embodiment a wound dressing is provided comprising a scaffold coated with a biologically active composition comprising a lipoic acid derivative. In a further embodiment, a system is provided for treating a tissue site of a patient, the system comprising a reduced-pressure source to supply reduced pressure, a manifold to distribute reduced pressure to a tissue site and a scaffold coated with a biologically active composition comprising a lipoic acid derivative. Methods for producing such a system and scaffold are also disclosed.